Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward C Keystone

Showing results (121-130 of 159) with videos related to

Pageof 16
Sort By:
RMD Open|October 12, 2017
Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate aloneEdward C Keystone, Ferdinand C Breedveld, Désirée van der Heijde, et al.
Arthritis Care & Research|June 9, 2022
Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational StudyBoulos Haraoui, Majed Khraishi, Denis Choquette, et al.
Annals of the Rheumatic Diseases|May 2, 2019
Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritisYoshiya Tanaka, Bruno Fautrel, Edward C Keystone, et al.
Annals of the Rheumatic Diseases|May 3, 2007
Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohortVeena K Ranganath, Jeonglim Yoon, Dinesh Khanna, et al.
The Journal of Rheumatology|November 18, 2009
Significance of clinical evaluation of the metacarpophalangeal joint in relation to synovial/bone pathology in rheumatoid and psoriatic arthritis detected by magnetic resonance imagingMillicent A Stone, Lawrence M White, Dafna D Gladman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 27, 2019
Comprehensive Profiling of the Rheumatoid Arthritis Antibody RepertoireKen C Lo, Eric Sullivan, Ryan M Bannen, et al.
Annals of the Rheumatic Diseases|August 24, 2012
Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexateJosef S Smolen, Désirée M van der Heijde, Edward C Keystone, et al.
Nature Genetics|August 16, 2011
The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsivenessJinyi Zhang, Naima Zahir, Qiuhong Jiang, et al.
ACR Open Rheumatology|March 29, 2022
Predictors of Influenza Vaccination in Early Rheumatoid Arthritis 2017-2021: Results From the Canadian Early Arthritis CohortViviane Ta, Orit Schieir, Marie-France Valois, et al.
Biologicals : Journal of the International Association of Biological Standardization|October 23, 2012
Health Canada/BIOTECanada Summit on regulatory and clinical topics related to subsequent entry biologics (biosimilars), Ottawa, Canada, 14 May 2012Jonathan Kay, Brian G Feagan, Micheal S Guirguis, et al.
Pageof 16

Showing results (121-130 of 159) with videos related to

Sort By:
Pageof 16
RMD Open|October 12, 2017
Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate aloneEdward C Keystone, Ferdinand C Breedveld, Désirée van der Heijde, et al.
Arthritis Care & Research|June 9, 2022
Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational StudyBoulos Haraoui, Majed Khraishi, Denis Choquette, et al.
Annals of the Rheumatic Diseases|May 2, 2019
Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritisYoshiya Tanaka, Bruno Fautrel, Edward C Keystone, et al.
Annals of the Rheumatic Diseases|May 3, 2007
Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohortVeena K Ranganath, Jeonglim Yoon, Dinesh Khanna, et al.
The Journal of Rheumatology|November 18, 2009
Significance of clinical evaluation of the metacarpophalangeal joint in relation to synovial/bone pathology in rheumatoid and psoriatic arthritis detected by magnetic resonance imagingMillicent A Stone, Lawrence M White, Dafna D Gladman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 27, 2019
Comprehensive Profiling of the Rheumatoid Arthritis Antibody RepertoireKen C Lo, Eric Sullivan, Ryan M Bannen, et al.
Annals of the Rheumatic Diseases|August 24, 2012
Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexateJosef S Smolen, Désirée M van der Heijde, Edward C Keystone, et al.
Nature Genetics|August 16, 2011
The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsivenessJinyi Zhang, Naima Zahir, Qiuhong Jiang, et al.
ACR Open Rheumatology|March 29, 2022
Predictors of Influenza Vaccination in Early Rheumatoid Arthritis 2017-2021: Results From the Canadian Early Arthritis CohortViviane Ta, Orit Schieir, Marie-France Valois, et al.
Biologicals : Journal of the International Association of Biological Standardization|October 23, 2012
Health Canada/BIOTECanada Summit on regulatory and clinical topics related to subsequent entry biologics (biosimilars), Ottawa, Canada, 14 May 2012Jonathan Kay, Brian G Feagan, Micheal S Guirguis, et al.
Pageof 16